SCHEMBL20892181

SCHEMBL20892181

CCCCCCCCC(CCCCCCC)OC(=O)CCCCCCCN(CCO)CCCCCCCC(=O)N(C)CCCCCCCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
MAPK1 P28482 2/20 0.49
EPHX2 P34913 2/20 0.44
PRKCA P17252 2/20 0.44
PRKCE Q02156 2/20 0.44
PRKCQ Q04759 2/20 0.44
PRKCD Q05655 2/20 0.44
LMNA P02545 4/20 0.44
ALDH1A1 P00352 1/20 0.44
CNR1 P21554 1/20 0.41
KDM5A P29375 3/20 0.41
PHF8 Q9UPP1 2/20 0.40
KDM4C Q9H3R0 1/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
MEN1 O00255 1/20 0.39
GMNN O75496 1/20 0.39
HSP90AA1 P07900 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18665197 1.00 MAPT (0.49) MAPTMAPK1EPHX2PRKCAPRKCE
SCHEMBL18665089 1.00 MAPT (0.49) MAPTMAPK1EPHX2PRKCAPRKCE
SCHEMBL22646140 1.00 MAPT (0.49) MAPTMAPK1EPHX2PRKCAPRKCE
SCHEMBL18641714 1.00 MAPT (0.49) MAPTMAPK1EPHX2PRKCAPRKCE
SCHEMBL26319645 0.93 MAPK1 (0.48) MAPTMAPK1EPHX2PRKCAPRKCE
SCHEMBL26319651 0.93 MAPK1 (0.48) MAPTMAPK1EPHX2PRKCAPRKCE
SCHEMBL24163833 0.91 MAPK1 (0.58) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL25411427 0.91 MAPK1 (0.58) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL21842903 0.91 MAPK1 (0.58) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL25410411 0.91 MAPK1 (0.58) MAPTMAPK1PRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10406113-B2 Combinations of mRNAs encoding immune modulating polypeptides and uses thereof MODERNATX, INC. (US) 2019-09-10 US disclosed
US-20190105281-A1 COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF ARES CAPITAL CORPORATION, AS AGENT 2019-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10406113-B2 Combinations of mRNAs encoding immune modulating polypeptides and uses thereof IL36G, IL23R, CD74 MAPT 4546/4885MAPK1 2097/4885EPHX2 3690/4885
US-20190105281-A1 COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF IL36G, IL23R, CD74 MAPT 4546/4885MAPK1 2097/4885EPHX2 3690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.